Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Zealand Pharma A/S (ZLDPF : OTC)

• Company Description    Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark. Number of Employees: 481

• Price / Volume Information    Yesterday's Closing Price: $34.50 Daily Weekly Monthly 20 Day Moving Average: 529 shares Shares Outstanding: 71.53 (millions) Market Capitalization: $2,467.63 (millions) Beta: 0.95 52 Week High: $83.12 52 Week Low: $33.39 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -19.96% -20.49% 12 Week -25.85% -30.06% Year To Date -51.82% -57.48%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Sydmarken 11 Soborg - Copenhagen,G7 2860 DNK ph: 45-8877-3600 fax: 45-8877-3898 investors@zealandpharma.com http://www.zealandpharma.com

• General Corporate Information    Officers Adam Steensberg - Chief Executive Officer and President Martin Nicklasson - Chairman of the Board of Directors Ivan Moller - Executive Vice President;Chief Operating Officer Henriette Wennicke - Executive Vice President and Chief Financial Offic Bernadette Connaughton - Director Peer Information Zealand Pharma A/S (CORR.) Zealand Pharma A/S (RSPI) Zealand Pharma A/S (CGXP) Zealand Pharma A/S (BGEN) Zealand Pharma A/S (GTBP) Zealand Pharma A/S (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: K9898X127 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/12/26 Share - Related Items Shares Outstanding: 71.53 Most Recent Split Date: (:1) Beta: 0.95 Market Capitalization: $2,467.63 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.89 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.65 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/26

• Fundamental Ratios P/E Current FY Estimate: 9.45 Trailing 12 Months: 5.72 PEG Ratio: - Price Ratios Price/Book: 0.88 Price/Cash Flow: 2.50 Price / Sales: 3.42 EPS Growth vs. Year Ago Period: -46.39% vs. Previous Quarter: 1,089.66% Sales Growth vs. Year Ago Period: -49.45% vs. Previous Quarter: 13,017.07% ROE 09/30/26 - - 06/30/26 - 17.56 03/31/26 - 41.80 ROA 09/30/26 - - 06/30/26 - 16.17 03/31/26 - 38.49 Current Ratio 09/30/26 - - 06/30/26 - 13.98 03/31/26 - 37.17 Quick Ratio 09/30/26 - - 06/30/26 - 13.98 03/31/26 - 37.17 Operating Margin 09/30/26 - - 06/30/26 - 58.86 03/31/26 - 68.82 Net Margin 09/30/26 - - 06/30/26 - 58.86 03/31/26 - 68.82 Pre-Tax Margin 09/30/26 - - 06/30/26 - 60.27 03/31/26 - 74.39 Book Value 09/30/26 - - 06/30/26 - 39.16 03/31/26 - 31.68 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - 0.17 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.02 03/31/26 - 0.02 Debt-to-Capital 09/30/26 - - 06/30/26 - 1.70 03/31/26 - 2.08

Powered by Zacks Investment Research ©